Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.

Reply to: The use of a non-inferiority analysis to establish a safe timeframe for prehabilitation.

Strous MTA, Janssen-Heijnen MLG, Jeroen Vogelaar F.

Eur J Surg Oncol. 2019 Oct 4. pii: S0748-7983(19)30873-X. doi: 10.1016/j.ejso.2019.09.186. [Epub ahead of print] No abstract available.

PMID:
31615706
2.

Functional bowel complaints and quality of life after surgery for colon cancer: prevalence and predictive factors.

van Heinsbergen M, den Haan N, Maaskant-Braat AJ, Melenhorst J, Belgers EH, Leijtens JW, Bloemen JG, Rutten HJ, Bouvy ND, Janssen-Heijnen ML, Konsten JL.

Colorectal Dis. 2019 Aug 9. doi: 10.1111/codi.14818. [Epub ahead of print]

PMID:
31397962
3.

Impact of therapeutic delay in colorectal cancer on overall survival and cancer recurrence - is there a safe timeframe for prehabilitation?

Strous MTA, Janssen-Heijnen MLG, Vogelaar FJ.

Eur J Surg Oncol. 2019 Jul 4. pii: S0748-7983(19)30546-3. doi: 10.1016/j.ejso.2019.07.009. [Epub ahead of print]

PMID:
31362842
4.

The low anterior resection syndrome in a reference population: prevalence and predictive factors in the Netherlands.

van Heinsbergen M, Van der Heijden JAG, Stassen LP, Melenhorst J, de Witte E, Belgers EH, Maaskant-Braat AJG, Bloemen JG, Bouvy ND, Janssen-Heijnen ML, Konsten JL.

Colorectal Dis. 2019 Jul 25. doi: 10.1111/codi.14790. [Epub ahead of print]

PMID:
31344293
5.

Quality of Life and Bowel Dysfunction after Transanal Endoscopic Microsurgery for Rectal Cancer: One Third of Patients Experience Major Low Anterior Resection Syndrome.

van Heinsbergen M, Leijtens JW, Slooter GD, Janssen-Heijnen ML, Konsten JL.

Dig Surg. 2019 Jun 11:1-8. doi: 10.1159/000496434. [Epub ahead of print]

PMID:
31185474
6.

Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.

de Kort S, Simons CCJM, van den Brandt PA, Janssen-Heijnen MLG, Sanduleanu S, Masclee AAM, Weijenberg MP.

Int J Cancer. 2019 Oct 1;145(7):1774-1781. doi: 10.1002/ijc.32365. Epub 2019 May 6.

7.

Is dietary supplement use longitudinally associated with fatigue in stage I-III colorectal cancer survivors?

Koole JL, Bours MJL, Breedveld-Peters JJL, van Roekel EH, Breukink SO, Janssen-Heijnen MLG, Vogelaar FJ, Aquarius M, Keulen E, Stoot J, Weijenberg MP.

Clin Nutr. 2019 Jan 29. pii: S0261-5614(19)30039-1. doi: 10.1016/j.clnu.2018.12.037. [Epub ahead of print]

8.

Study Protocol of the NVALT25-ELDAPT Trial: Selecting the Optimal Treatment for Older Patients With Stage III Non-small-cell Lung Cancer.

Driessen EJM, Janssen-Heijnen MLG, Maas HA, Dingemans AC, van Loon JGM.

Clin Lung Cancer. 2018 Nov;19(6):e849-e852. doi: 10.1016/j.cllc.2018.07.003. Epub 2018 Jul 9.

PMID:
30097357
9.

Changes in treatment patterns and survival in elderly patients with stage I non-small-cell lung cancer with the introduction of stereotactic body radiotherapy and video-assisted thoracic surgery.

Detillon DDEMA, Driessen EJM, Aarts MJ, Janssen-Heijnen MLG, van Eijck CHJ, Veen EJ.

Eur J Cancer. 2018 Sep;101:30-37. doi: 10.1016/j.ejca.2018.06.016. Epub 2018 Jul 14.

PMID:
30014972
10.

Bowel dysfunction after sigmoid resection underestimated: Multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid.

van Heinsbergen M, Janssen-Heijnen ML, Leijtens JW, Slooter GD, Konsten JL.

Eur J Surg Oncol. 2018 Aug;44(8):1261-1267. doi: 10.1016/j.ejso.2018.05.003. Epub 2018 May 9.

PMID:
29778617
11.

Patient- and tumor-related predictors of chemotherapy intolerance in older patients with cancer: A systematic review.

van Abbema DL, van den Akker M, Janssen-Heijnen ML, van den Berkmortel F, Hoeben A, de Vos-Geelen J, Buntinx F, Kleijnen J, Tjan-Heijnen VCG.

J Geriatr Oncol. 2019 Jan;10(1):31-41. doi: 10.1016/j.jgo.2018.04.001. Epub 2018 Apr 26. Review.

12.

Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.

de Jong RGPJ, Peeters PJHL, Burden AM, de Bruin ML, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Cancer Epidemiol. 2018 Jun;54:104-111. doi: 10.1016/j.canep.2018.04.008. Epub 2018 May 16.

PMID:
29705628
13.

Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.

Driessen EJM, van Loon JGM, Maas HA, Dingemans AC, Janssen-Heijnen MLG.

Lung. 2018 Aug;196(4):463-468. doi: 10.1007/s00408-018-0116-8. Epub 2018 Apr 12.

PMID:
29651598
14.

Patterns of treatment and survival among older patients with stage III non-small cell lung cancer.

Driessen EJM, Schulkes KJG, Dingemans AC, van Loon JGM, Hamaker ME, Aarts MJ, Janssen-Heijnen MLG.

Lung Cancer. 2018 Feb;116:55-61. doi: 10.1016/j.lungcan.2017.12.013. Epub 2017 Dec 20.

PMID:
29413051
15.

Preoperative segmental localization of colorectal carcinoma: CT colonography vs. optical colonoscopy.

Offermans T, Vogelaar FJ, Aquarius M, Janssen-Heijnen MLG, Simons PCG.

Eur J Surg Oncol. 2017 Nov;43(11):2105-2111. doi: 10.1016/j.ejso.2017.09.016. Epub 2017 Sep 20.

PMID:
28965706
16.

Detection of potentially relevant extracolonic and colorectal findings at CT colonography in a low-risk symptomatic patient population.

Netz FRS, Pickhardt PJ, Janssen Heijnen MLG, Simons PCG.

Abdom Radiol (NY). 2017 Dec;42(12):2799-2806. doi: 10.1007/s00261-017-1221-5.

PMID:
28647771
17.

Lung Cancer in the Oldest Old: A Nation-Wide Study in The Netherlands.

Schulkes KJG, Pouw CAM, Driessen EJM, van Elden LJR, van den Bos F, Janssen-Heijnen MLG, Lammers JJ, Hamaker ME.

Lung. 2017 Oct;195(5):627-634. doi: 10.1007/s00408-017-0026-1. Epub 2017 Jun 19.

PMID:
28631153
18.

Trends in treatment and relative survival among Non-Small Cell Lung Cancer patients in the Netherlands (1990-2014): Disparities between younger and older patients.

Driessen EJ, Aarts MJ, Bootsma GP, van Loon JG, Janssen-Heijnen ML.

Lung Cancer. 2017 Jun;108:198-204. doi: 10.1016/j.lungcan.2017.04.005. Epub 2017 Apr 10.

PMID:
28625635
19.

Impact of Relative Conditional Survival Estimates on Patient Prognosis After Percutaneous Coronary Intervention.

Baart SJ, van Domburg RT, Janssen-Heijnen MLG, Deckers JW, Akkerhuis KM, Daemen J, van Geuns RJ, Boersma E, Kardys I.

Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6). pii: e003344. doi: 10.1161/CIRCOUTCOMES.116.003344.

PMID:
28619724
20.

Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross-sectional population-based study.

de Kort S, Bouwens MW, Weijenberg MP, Janssen-Heijnen ML, de Bruïne AP, Riedl R, Masclee AA, Sanduleanu S.

United European Gastroenterol J. 2017 Apr;5(3):415-423. doi: 10.1177/2050640616664271. Epub 2016 Aug 9.

21.

Effects of prehabilitation and rehabilitation including a home-based component on physical fitness, adherence, treatment tolerance, and recovery in patients with non-small cell lung cancer: A systematic review.

Driessen EJ, Peeters ME, Bongers BC, Maas HA, Bootsma GP, van Meeteren NL, Janssen-Heijnen ML.

Crit Rev Oncol Hematol. 2017 Jun;114:63-76. doi: 10.1016/j.critrevonc.2017.03.031. Epub 2017 Apr 5. Review.

PMID:
28477748
22.

Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus.

de Jong RGPJ, Burden AM, de Kort S, van Herk-Sukel MPP, Vissers PAJ, Janssen PKC, Haak HR, Masclee AAM, de Vries F, Janssen-Heijnen MLG.

Eur J Cancer. 2017 Jul;79:61-71. doi: 10.1016/j.ejca.2017.03.039. Epub 2017 Apr 29.

PMID:
28463757
23.

Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation.

de Kort S, Masclee AAM, Sanduleanu S, Weijenberg MP, van Herk-Sukel MPP, Oldenhof NJJ, van den Bergh JPW, Haak HR, Janssen-Heijnen ML.

Sci Rep. 2017 Apr 24;7:46527. doi: 10.1038/srep46527.

24.

Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.

Schmidt MK, van den Broek AJ, Tollenaar RA, Smit VT, Westenend PJ, Brinkhuis M, Oosterhuis WJ, Wesseling J, Janssen-Heijnen ML, Jobsen JJ, Jager A, Voogd AC, van Leeuwen FE, van 't Veer LJ.

J Natl Cancer Inst. 2017 Aug 1;109(8). doi: 10.1093/jnci/djw329.

PMID:
28376189
25.

No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure.

de Jong RG, Burden AM, de Kort S, van Herk-Sukel MP, Vissers PA, Janssen PK, Haak HR, Masclee AA, de Vries F, Janssen-Heijnen ML.

Cancer Prev Res (Phila). 2017 May;10(5):290-297. doi: 10.1158/1940-6207.CAPR-16-0277. Epub 2017 Mar 8.

26.

Stage III Non-Small Cell Lung Cancer in the elderly: Patient characteristics predictive for tolerance and survival of chemoradiation in daily clinical practice.

Driessen EJ, Bootsma GP, Hendriks LE, van den Berkmortel FW, Bogaarts BA, van Loon JG, Dingemans AC, Janssen-Heijnen ML.

Radiother Oncol. 2016 Oct;121(1):26-31. doi: 10.1016/j.radonc.2016.07.025. Epub 2016 Aug 10.

PMID:
27522577
27.

Epidemiology, management and survival outcomes of primary cutaneous melanoma: a ten-year overview.

Aubuchon MM, Bolt LJ, Janssen-Heijnen ML, Verleisdonk-Bolhaar ST, van Marion A, van Berlo CL.

Acta Chir Belg. 2017 Feb;117(1):29-35. doi: 10.1080/00015458.2016.1242214. Epub 2016 Oct 23.

PMID:
27774842
28.

The Course of Neuropathic Symptoms in Relation to Adjuvant Chemotherapy Among Elderly Patients With Stage III Colon Cancer: A Longitudinal Study.

van Erning FN, Janssen-Heijnen MLG, Wegdam JA, Slooter GD, Wijsman JH, Vreugenhil A, Beijers TAJM, van de Poll-Franse LV, Lemmens VEPP.

Clin Colorectal Cancer. 2017 Sep;16(3):195-203. doi: 10.1016/j.clcc.2016.09.002. Epub 2016 Sep 17.

PMID:
27756521
29.

Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.

van Erning FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, Maas HA, Lemmens VE.

Int J Cancer. 2017 Jan 1;140(1):224-233. doi: 10.1002/ijc.30423. Epub 2016 Sep 22.

30.

Comparability of the age and sex distribution of the UK Clinical Practice Research Datalink and the total Dutch population.

de Jong RG, Gallagher AM, Herrett E, Masclee AA, Janssen-Heijnen ML, de Vries F.

Pharmacoepidemiol Drug Saf. 2016 Dec;25(12):1460-1464. doi: 10.1002/pds.4074. Epub 2016 Jul 27.

31.

Comments on "Use of metformin and risk of kidney cancer in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25.

de Jong RG, Nielen JT, Masclee AA, Janssen-Heijnen ML, de Vries F.

Eur J Cancer. 2016 Jul;61:157-8. doi: 10.1016/j.ejca.2016.03.065. Epub 2016 Apr 27. No abstract available.

PMID:
27131610
32.

Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patients.

van Erning FN, Razenberg LG, Lemmens VE, Creemers GJ, Pruijt JF, Maas HA, Janssen-Heijnen ML.

Eur J Cancer. 2016 Jul;61:1-10. doi: 10.1016/j.ejca.2016.03.074. Epub 2016 Apr 27.

PMID:
27128782
33.

Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.

de Kort S, Simons CC, van den Brandt PA, Goldbohm RA, Arts IC, de Bruine AP, Janssen-Heijnen ML, Sanduleanu S, Masclee AA, Weijenberg MP.

Eur J Gastroenterol Hepatol. 2016 Aug;28(8):896-903. doi: 10.1097/MEG.0000000000000626.

PMID:
27097356
34.

Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.

van den Broek AJ, van 't Veer LJ, Hooning MJ, Cornelissen S, Broeks A, Rutgers EJ, Smit VT, Cornelisse CJ, van Beek M, Janssen-Heijnen ML, Seynaeve C, Westenend PJ, Jobsen JJ, Siesling S, Tollenaar RA, van Leeuwen FE, Schmidt MK.

J Clin Oncol. 2016 Feb 10;34(5):409-18. doi: 10.1200/JCO.2015.62.3942. Epub 2015 Dec 23.

PMID:
26700119
35.

Evaluation of nutritional status as an independent predictor of post-operative complications and morbidity after gastro-intestinal surgery.

van der Kroft G, Janssen-Heijnen MLG, van Berlo CLH, Konsten JLM.

Clin Nutr ESPEN. 2015 Aug;10(4):e129-e133. doi: 10.1016/j.clnesp.2015.05.005. Epub 2015 Jun 19.

PMID:
28531389
36.

Deciding on adjuvant chemotherapy for elderly patients with stage III colon cancer: a qualitative insight into the perspectives of surgeons and medical oncologists.

van Erning FN, Janssen-Heijnen ML, Creemers GJ, Pruijt HF, Maas HA, Lemmens VE.

J Geriatr Oncol. 2015 May;6(3):219-24. doi: 10.1016/j.jgo.2015.02.001. Epub 2015 Feb 20.

PMID:
25703856
37.

Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis.

Janssen-Heijnen ML, van Erning FN, De Ruysscher DK, Coebergh JW, Groen HJ.

Ann Oncol. 2015 May;26(5):902-7. doi: 10.1093/annonc/mdv061. Epub 2015 Feb 11.

PMID:
25672893
38.

Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer.

Koopal C, Janssen-Heijnen ML, van de Wouw AJ, van den Bergh JP.

Breast. 2015 Apr;24(2):153-8. doi: 10.1016/j.breast.2014.12.008. Epub 2015 Jan 22.

39.

Prospective evaluation of the added value of imaging within the Dutch National Diagnostic Appendicitis Guideline--do we forget our clinical eye?

Schok T, Simons PC, Janssen-Heijnen ML, Peters NA, Konsten JL.

Dig Surg. 2014;31(6):436-43. doi: 10.1159/000369587. Epub 2015 Jan 14.

PMID:
25592145
40.

Sigmoid cancer versus chronic diverticular disease: differentiating features at CT colonography.

Lips LM, Cremers PT, Pickhardt PJ, Cremers SE, Janssen-Heijnen ML, de Witte MT, Simons PC.

Radiology. 2015 Apr;275(1):127-35. doi: 10.1148/radiol.14132829. Epub 2014 Nov 26.

PMID:
25426771
41.

International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.

Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen ML, Extermann M, Falandry C, Artz A, Brain E, Colloca G, Flamaing J, Karnakis T, Kenis C, Audisio RA, Mohile S, Repetto L, Van Leeuwen B, Milisen K, Hurria A.

J Clin Oncol. 2014 Aug 20;32(24):2595-603. Review.

42.

The effect of 3% and 6% hypertonic saline in viral bronchiolitis: a randomised controlled trial.

Teunissen J, Hochs AH, Vaessen-Verberne A, Boehmer AL, Smeets CC, Brackel H, van Gent R, Wesseling J, Logtens-Stevens D, de Moor R, Rosias PP, Potgieter S, Faber MR, Hendriks HJ, Janssen-Heijnen ML, Loza BF.

Eur Respir J. 2014 Oct;44(4):913-21. doi: 10.1183/09031936.00159613. Epub 2014 Jun 25.

43.

Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?

van Erning FN, van Steenbergen LN, Lemmens VEPP, Rutten HJT, Martijn H, van Spronsen DJ, Janssen-Heijnen MLG.

Eur J Cancer. 2014 Jul;50(10):1731-1739. doi: 10.1016/j.ejca.2014.04.009. Epub 2014 May 6.

PMID:
24814358
44.

Four screening instruments for frailty in older patients with and without cancer: a diagnostic study.

Smets IH, Kempen GI, Janssen-Heijnen ML, Deckx L, Buntinx FJ, van den Akker M.

BMC Geriatr. 2014 Feb 26;14:26. doi: 10.1186/1471-2318-14-26.

45.

Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer.

Janssen-Heijnen ML, Maas HA, Koning CC, van der Bruggen-Bogaarts BA, Groen HJ, Wymenga AN.

J Geriatr Oncol. 2014 Jan;5(1):71-7. doi: 10.1016/j.jgo.2013.07.008. Epub 2013 Sep 7.

PMID:
24484721
46.

Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?

van den Broek EC, Liu L, Posthuma EF, Janssen-Heijnen ML, Coebergh JW, Soerjomataram I.

Ann Hematol. 2014 Jan;93(1):157-62. doi: 10.1007/s00277-013-1929-4. Epub 2013 Oct 25.

PMID:
24381068
47.

Conditional survival of malignant melanoma in The Netherlands: 1994-2008.

van der Leest RJ, van Steenbergen LN, Hollestein LM, de Vries E, Nijsten T, van Akkooi AC, Janssen-Heijnen ML, Coebergh JW.

Eur J Cancer. 2014 Feb;50(3):602-10. doi: 10.1016/j.ejca.2013.10.019. Epub 2013 Nov 18.

PMID:
24262585
48.

Small but significant excess mortality compared with the general population for long-term survivors of breast cancer in the Netherlands.

Janssen-Heijnen ML, van Steenbergen LN, Voogd AC, Tjan-Heijnen VC, Nijhuis PH, Poortmans PM, Coebergh JW, van Spronsen DJ.

Ann Oncol. 2014 Jan;25(1):64-8. doi: 10.1093/annonc/mdt424. Epub 2013 Nov 7.

PMID:
24201973
49.

Patients with prostate cancer continue to have excess mortality up to 15 years after diagnosis.

Husson O, van Steenbergen LN, Koldewijn EL, Poortmans PM, Coebergh JW, Janssen-Heijnen ML.

BJU Int. 2014 Nov;114(5):691-7. doi: 10.1111/bju.12519. Epub 2014 Feb 20.

50.

Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands.

van de Schans SA, van Steenbergen LN, Coebergh JW, Janssen-Heijnen ML, van Spronsen DJ.

Haematologica. 2014 Feb;99(2):339-45. doi: 10.3324/haematol.2012.081885. Epub 2013 Sep 13.

Supplemental Content

Loading ...
Support Center